Cargando…

Targeting interleukin-1 receptor-associated kinase 1 for human hepatocellular carcinoma

BACKGROUND: Interleukin-1 receptor associated kinase 1 (IRAK1), as a down-stream of toll-like receptor (TLR) signaling, plays important roles in series of malignancies. However, the role of IRAK1 in hepatocellular carcinoma (HCC) remains little known. METHODS: In our study, reverse transcription-PCR...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Ning, Jiang, Jinhua, Fu, Jing, Yu, Ting, Wang, Bibo, Qin, Wenhao, Xu, An, Wu, Mengchao, Chen, Yao, Wang, Hongyang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5020546/ https://www.ncbi.nlm.nih.gov/pubmed/27619757 http://dx.doi.org/10.1186/s13046-016-0413-0

Ejemplares similares

ACADL plays a tumor-suppressor role by targeting Hippo/YAP signaling in hepatocellular carcinoma
por: Zhao, Xiaofang, et al.
Publicado: (2020)

The identification and functional analysis of CD8+PD-1+CD161+ T cells in hepatocellular carcinoma
por: Li, Zhixuan, et al.
Publicado: (2020)

Identification of sphingosine kinase 1 (SphK1) as a primary target of icaritin in hepatocellular carcinoma cells
por: Lu, Pei-Hua, et al.
Publicado: (2017)

Endotoxin Tolerant Dendritic Cells Suppress Inflammatory Responses in Splenocytes via Interleukin-1 Receptor Associated Kinase (IRAK)-M and Programmed Death-Ligand 1 (PDL-1)
por: Zhou, Yuping, et al.
Publicado: (2018)

Defining the functional binding sites of interleukin 12 receptor β1 and interleukin 23 receptor to Janus kinases
por: Floss, Doreen M., et al.
Publicado: (2016)

The synergistic effect of sorafenib and TNF-α inhibitor on hepatocellular carcinoma
por: Wang, Mingda, et al.
Publicado: (2019)

Axl Expression Stratifies Patients with Poor Prognosis after Hepatectomy for Hepatocellular Carcinoma
por: Liu, Jian, et al.
Publicado: (2016)

Circulating interleukin-1β promotes endoplasmic reticulum stress-induced myocytes apoptosis in diabetic cardiomyopathy via interleukin-1 receptor-associated kinase-2
por: Liu, Zhongwei, et al.
Publicado: (2015)

Association Between Polymorphisms of Interleukin 1 Family Genes and Hepatocellular Carcinoma
por: Tak, Ki Hong, et al.
Publicado: (2018)

High interleukin-8 and/or extracellular signal-regulated kinase 2 expression predicts poor prognosis in patients with hepatocellular carcinoma
por: Deng, Youyuan, et al.
Publicado: (2019)

Research progress of targeted therapy combined with immunotherapy for hepatocellular carcinoma
por: Xie, Shuqi, et al.
Publicado: (2023)

Inhibition of interleukin-1 receptor-associated kinase 1 (IRAK1) as a therapeutic strategy
por: Singer, Jack W., et al.
Publicado: (2018)

Interleukin‐23 receptor defines T helper 1‐like regulatory T cells in oral squamous cell carcinoma
por: Li, Wei, et al.
Publicado: (2022)

Asialoglycoprotein receptor-magnetic dual targeting nanoparticles for delivery of RASSF1A to hepatocellular carcinoma
por: Xue, Wan-Jiang, et al.
Publicado: (2016)

MAP Kinase-Interacting Kinase 1 Promotes Proliferation and Invasion of Hepatocellular Carcinoma and Is an Unfavorable Prognostic Biomarker
por: Wang, Xujing, et al.
Publicado: (2018)

The Role of Interleukin-1 Receptor-Associated Kinases in Vogt-Koyanagi-Harada Disease
por: Sun, Min, et al.
Publicado: (2014)

Interleukin-1 Receptor-Associated Kinase 4 Deficiency in a Greek Teenager
por: Karananou, Panagiota, et al.
Publicado: (2020)

Interleukin Receptor Associated Kinase 1 Signaling and Its Association with Cardiovascular Diseases
por: Zheng, Youjing, et al.
Publicado: (2022)

Relevance of Serum Levels of Interleukin-6 and Syndecan-1 in Patients with Hepatocellular Carcinoma
por: Metwaly, Heba A., et al.
Publicado: (2012)

Interleukin-1 receptor-associated kinase 4 as a potential biomarker: Overexpression predicts poor prognosis in patients with glioma
por: Wang, Jialin, et al.
Publicado: (2021)

NQO1 promotes an aggressive phenotype in hepatocellular carcinoma via amplifying ERK‐NRF2 signaling
por: Yang, Yun, et al.
Publicado: (2020)

Neuraminidase 1 (NEU1) promotes proliferation and migration as a diagnostic and prognostic biomarker of hepatocellular carcinoma
por: Hou, Guojun, et al.
Publicado: (2016)

Interleukin-2 inducible T-cell kinase: a potential prognostic biomarker and tumor microenvironment remodeling indicator for hepatocellular carcinoma
por: Pan, Binhua, et al.
Publicado: (2021)

The Role of AMP-Activated Protein Kinase as a Potential Target of Treatment of Hepatocellular Carcinoma
por: Jiang, Xue, et al.
Publicado: (2019)

Sorafenib promotes hepatocellular carcinoma invasion via interleukin-6/HIF-1α/PFKFB3
por: Zhuang, Pengyuan, et al.
Publicado: (2023)

Vitamin C preferentially kills cancer stem cells in hepatocellular carcinoma via SVCT-2
por: Lv, Hongwei, et al.
Publicado: (2018)

c-MET receptor tyrosine kinase as a molecular target in advanced hepatocellular carcinoma
por: Granito, Alessandro, et al.
Publicado: (2015)

Interleukin-1 antagonists in Mevalonate Kinase Deficiency
por: Galeotti, C, et al.
Publicado: (2011)

Interleukin-8 Producing Hepatocellular Carcinoma with Pyrexia
por: Harimoto, Norifumi, et al.
Publicado: (2009)

Detection of Circulating Tumor Cells in Hepatocellular Carcinoma Using Antibodies against Asialoglycoprotein Receptor, Carbamoyl Phosphate Synthetase 1 and Pan-Cytokeratin
por: Li, Jun, et al.
Publicado: (2014)

Protease-activated receptor-1 (PAR1) promotes epithelial-endothelial transition through Twist1 in hepatocellular carcinoma
por: Xiao, Ting, et al.
Publicado: (2018)

OATP1B1 Plays an Important Role in the Transport and Treatment Efficacy of Sorafenib in Hepatocellular Carcinoma
por: Wen, Jinhua, et al.
Publicado: (2021)

Oncogenic tuftelin 1 as a potential molecular-targeted for inhibiting hepatocellular carcinoma growth
por: Wu, Meng-Na, et al.
Publicado: (2021)

LRG1 expression indicates unfavorable clinical outcome in hepatocellular carcinoma
por: Wang, Chun-Hua, et al.
Publicado: (2015)

Interleukin-1 receptor associated kinase 1 (IRAK1) is epigenetically activated in luminal epithelial cells in prostate cancer
por: Schagdarsurengin, Undraga, et al.
Publicado: (2022)

miR-146a-5p targets interleukin-1 receptor-associated kinase 1 to inhibit the growth, migration, and invasion of breast cancer cells
por: Long, Jing-Pei, et al.
Publicado: (2019)

Targeting high Aurora kinases expression as an innovative therapy for hepatocellular carcinoma
por: Liu, Fuchen, et al.
Publicado: (2017)

Target Therapy for Hepatocellular Carcinoma: Beyond Receptor Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors
por: Park, Hyunjung, et al.
Publicado: (2022)

OCT4 increases BIRC5 and CCND1 expression and promotes cancer progression in hepatocellular carcinoma
por: Cao, Lu, et al.
Publicado: (2013)

Association of Interleukin-1 Beta and Interleukin-1 Receptor Antagonist Gene Polymorphisms and Plasma Levels with Diabetic Nephropathy
por: Liao, Xueling, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7gpfipgl2v0f14pdjsku1mrbi3